Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Heart Failure IV: Classification and Diagnostic Evaluation

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

Diagnostic and Statistical Manual of Mental Disorders (DSM)

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Classification of Illness

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Differential susceptibility of hair colour changes after barzolvolimab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Same author

Randomized dose-finding study of anti-KIT barzolvolimab in patients with chronic spontaneous urticaria.

The Journal of allergy and clinical immunology·2026

Same author

Psychiatric Comorbidities and Weight Loss Recommendations in Bariatric Surgery Patients.

Rhode Island medical journal (2013)·2025

Same author

On the Kinetics of Human Skin Mast Cell Depletion and Repopulation Following KIT Inhibition.

Allergy·2025

Same author

Variables Associated With Non-Response in Anxiety and Depression Among Patients Receiving Treatment in a Partial Hospitalization Program.

Journal of clinical psychology·2025

Same author

Anti-KIT Barzolvolimab for Chronic Spontaneous Urticaria.

Allergy·2025

Search research articles

Related Experiment Video

Updated: May 10, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Severity classification on the Hamilton Depression Rating Scale.

Mark Zimmerman¹, Jennifer H Martinez, Diane Young

¹Department of Psychiatry and Human Behavior, Brown Medical School, Rhode Island Hospital, 146 West River Street, Providence, RI, United States. mzimmerman@lifespan.org

Journal of Affective Disorders

|June 14, 2013

Summary

This summary is machine-generated.

This study establishes new cutoff scores for the Hamilton Depression Rating Scale (HAMD) to accurately classify depression severity. Recommended HAMD ranges aid in better understanding patient conditions and treatment response.

Keywords:

Depression Hamilton depression rating scale Severity

More Related Videos

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Related Experiment Videos

Last Updated: May 10, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Area of Science:

Psychiatry
Clinical Psychology
Psychometric Research

Background:

Debate persists regarding symptom severity as a moderator of depression treatment response.
Previous meta-analyses used varying Hamilton Depression Rating Scale (HAMD) cutoffs for severe depression.
Limited empirical data exists for HAMD severity band cutoffs.

Purpose of the Study:

To empirically establish reliable cutoff scores on the HAMD for classifying depression severity.
To define distinct severity groups (mild, moderate, severe) using HAMD scores.

Main Methods:

Evaluated 627 outpatients with major depressive disorder using semi-structured interviews.
Derived 17-item HAMD scores via the Endicott et al. (1981) conversion method.
Utilized receiver operating curves to determine optimal cutoffs for mild vs. moderate and moderate vs. severe depression.

Main Results:

Significantly lower HAMD scores were observed in mild vs. moderate, and moderate vs. severe depression groups.
Optimal HAMD cutoff for mild vs. moderate depression was 17.
Optimal HAMD cutoff for moderate vs. severe depression was 24.

Conclusions:

Recommended HAMD severity ranges: no depression (0-7), mild (8-16), moderate (17-23), and severe (≥24).
Findings provide empirical support for HAMD score interpretation in major depressive disorder.
Study conducted in a diverse outpatient setting, enhancing generalizability of recommended cutoffs.